The next decade promises to be transformative for peptide research, with trends including AI-driven design, expanded oral delivery, multi-target agonists, and sustainable manufacturing shaping the future of the field. The peptide therapeutics market is projected to reach US$ 189.5 billion by 2032[reference:164], reflecting the growing importance of peptides in medicine.
AI-driven design is revolutionizing peptide discovery, with deep learning models capable of generating de novo peptide agonists with predicted biological activity[reference:165]. These AI approaches are accelerating discovery timelines and expanding the range of targets that can be addressed with peptide therapeutics. Generative AI is being applied to peptide antibiotic optimization[reference:166] and anti-diabetic peptide design[reference:167].
Oral peptide delivery is achieving breakthrough milestones, with novel permeation enhancers and enteric coating technologies enabling subcutaneous-to-oral switching of blockbuster drugs[reference:168]. The global oral proteins and peptides market is projected to grow from USD 9.31 billion in 2025 to USD 19.93 billion by 2030[reference:169].
Multi-target peptide agonists are emerging as the next frontier, demonstrating superior efficacy in metabolic disorders. Tirzepatide (dual GLP-1/GIP) has shown superior efficacy compared to selective GLP-1 agonists[reference:170], and triple agonists are in development. These approaches are expanding the therapeutic possibilities for peptide drugs.
Sustainable manufacturing is becoming increasingly important, with pressure to reduce reliance on toxic solvents and adopt more efficient approaches[reference:171]. Greener synthesis methods including solvent-less coupling[reference:172] and wash-free methodologies[reference:173] are being developed and adopted.
At PeptideHub, we are committed to staying at the forefront of these trends, providing our customers with the peptides and services they need for cutting-edge research and development. Our investment in AI-driven design, advanced manufacturing, and sustainable approaches ensures that we remain a trusted partner for peptide research.